Board of Directors
Steer the business direction and management focus, and monitor regularly the company operation and financial performance.
Executive Director
-
Mr. Fang Wen Quan
Details
Mr. FANG Wen Quan has been appointed as an Executive Director since 6 October 2003. He is currently the Chairman, the Managing Director, the chairman of the nomination committee and a member of the remuneration committee and the risk management committee of the Company, and a director of the Group’s certain subsidiaries. Mr. Fang is the founder, chairman and beneficial owner of Tianda Group Limited (the controlling shareholder of the Company). Mr. Fang is currently the chairman of the board of directors, general manager and authorized representative of Tianda Culture Holdings (China) Limited (listed on the National Equities Exchange and Quotations Systems, company code: 837889). Mr. Fang studied International Relations at the University of Sydney and Tsinghua University. He has ample experience in corporate strategy and management. He also established "Tianda Institute", a non-profit strategic studies think tank. Committed to the mission of “Caring for a Better World”, Mr. Fang has all along provided financial support to communities in need, including donations to people living in the property, education and talent development, healthcare, scientific research and environmental protection, culture and arts.
-
Mr. Lui Man Sang
Details
Mr. LUI Man Sang has been appointed as an Executive Director of the Company since 30 September 2013 and is a director of the Group’s certain subsidiaries. Mr. Lui joined Tianda Group, the controlling shareholder of the Company in 2007 and is the deputy general manager of Tianda Group. He is responsible for the financial management of Tianda Group and the Company. Mr. Lui is a director of Tianda Culture Holdings (China) Limited (listed on the National Equities Exchange and Quotations, company code: 837889). Mr. Lui possesses enriched financial management experience covering a variety of industries including auditing in one of the big four accounting firms in Hong Kong and overseeing the finance department of a Hong Kong listed company. He holds an Executive MBA granted by City University of Hong Kong. He is a fellow member of the Association of Chartered Certified Accountants and the Hong Kong Institute of Certified Public Accountants.
Non-Executive Director
-
Mr. Zhong Tao
Details
Mr. ZHONG Tao has been appointed as a Non-executive Director and a member of the audit committee of the Company since 29 August 2023. He is currently the vice president, board secretary and joint company secretary of Shanghai Pharmaceuticals Holding Co., Ltd. (a company listed on the Shanghai Stock Exchange with stock code 601607, and The Stock Exchange of Hong Kong Limited (“Hong Kong Stock Exchange”) with stock code 02607). Mr. ZHONG previously served as an executive director and a vice president of Shanghai Industrial Urban Development Group Limited (a company listed on Hong Kong Stock Exchange with stock code 00563); and held several management positions in other companies including Shanghai Industrial Management (Shanghai) Company Limited., Shanghai Galaxy Digital Investment Company Limited., and Shanghai Industrial Real Property Group (Shanghai) Company Limited. etc.
Mr. ZHONG holds a master’s degree in Business Management from Fudan University.
-
Mr. Feng Quanming
Details
Mr. FENG Quanming has been appointed as a Non-executive Director since 23 March 2016. Mr. Feng is Chief Financial Officer of Hongta Tabacco (Group) Limited (Hongta), which holds 9.66% equity interest in the Company. He has extensive experience in corporate financial accounting and asset management. Mr. Feng joined Hongta in July 2001. During the period from August 2007 to January 2022, he took various positions in the finance department of Hongta, including deputy head of industrial finance division, head and deputy head of asset management division, head of general management division, head of the finance department. He was also the head of financial planning division of Yunnan Hongta Group Co., Ltd, a wholly-owned subsidiary of Hongta, during the period from June 2013 to August 2014. Mr. Feng obtained his bachelor degree in accounting at Southwestern University of Finance and Economics in 2001 and master in business administration at Renmin University of China in 2009. Mr. Feng possesses the qualification of practising certified public accountant in mainland China.
Independent Non-Executive Director
-
Mr. Lam Yat Fai
Details
Mr. LAM Yat Fai has been appointed as an Independent Non-executive Director, a member of the remuneration committee and a member of audit committee of the Company in 2004. On 26 November 2013, he was appointed as the chairman of the audit committee. He was appointed as a member of nomination committee and risk management committee on 22 July 2009. He is a Certified Public Accountant (Practising). He is also a fellow member of the Hong Kong Institute of Certified Public Accountants and a fellow member of the Association of Chartered Certified Accountants. Mr. Lam has accumulated rich experience in auditing, taxation, corporate finance and accounting over the years. Mr. Lam is an independent non-executive director of Oriental Enterprise Holdings Limited (formerly known as Oriental Press Group Limited) (stock code: 0018), which is listed on the Main Board of the Hong Kong Stock Exchange.
-
Mr. Chiu Sung Hong
Details
Mr. CHIU Sung Hong was appointed as an Independent Non-executive Director, the chairman of the audit committee of the Company with effect from 10 April 2008. Mr. Chiu ceased to act as the chairman of the audit committee and remained as a member of the committee on 26 November 2013. Mr. Chiu was appointed as the chairman of risk management committee on 22 July 2009. On 1 April 2012, he was appointed as the chairman of the remuneration committee and a member of the nomination committee. He received an LL.B. degree from the University of Sydney. He was admitted as a solicitor of the Supreme Court of New South Wales and the High Court of Australia. He has over 40 years of experience in legal practice. Mr. Chiu is the founding member of the Board of Trustees of the Australian Nursing Home Foundation and a senior research fellow of Centre for Law & Globalization of Renmin University of China. He also served as the General Secretary of Australian Chinese Community Association of New South Wales. Mr. Chiu is an independent non-executive director of CNOOC Limited (a company listed on the Shanghai Stock Exchange with stock code 600938, and Hong Kong Stock Exchange with stock code: 0883), which is listed on the Main Board of the Hong Kong Stock Exchange and Bank of China (Australia) Limited.
-
Dr. Xian Yanfang
Details
Dr. Xian Yanfang (“Dr. Xian”), has been appointed as an independent non-executive director and a member of the Audit Committee and Remuneration Committee of the Company since 27 June 2023.
Dr. Xian is an assistant professor of School of Chinese Medicine, The Chinese University of Hong Kong. She has extensive research experience in the field of Pharmacology of Chinese medicines, Herb-drug interactions of Chinese and western medicines and Quality control of Chinese medicines. Dr. Xian is currently a project review expert of National Natural Science Foundation of China, the general secretary of Hong Kong Association of Chinese Herbal Pharmacology, a member of technical support team in Pharmacology and Toxicology of The Hong Kong Government Chinese Medicines Testing Institute, the committee member of Deficiency Syndrome and Geriatrics Professional Committee of China Association of Integrative Medicine, and a member of Branch of Integrative Traditional Chinese and Western Medicine of the China Association of Gerontology and Geriatrics.
Dr. Xian holds a Ph.D degree in Chinese Medicine from The Chinese University of Hong Kong, and a master’s degree and a bachelor’s degree in Science of Chinese Materia Medica from Guangzhou University of Chinese Medicine.
List of Directors and their Role and Function
Sub-committees are set up under the Board of Directors for monitoring different aspects of the company operation.
Audit Committee
The management staff are properly serving their roles and responsibilities by reviewing and monitoring the duties of the appointed auditor on the basis of independence, objective and validity; examining the annual and interim Financial Statements before submission for Board of Directors ‘approval; and reviewing the financial control, internal audit and risk management system of the company.
Audit Committee Members
Mr. Lam Yat Fai - INED (Chairman)
Mr. Zhong Tao - NED
Mr. Chiu Sung Hong - INED
Dr. Xian Yanfang - INED
Nomination Committee
Set up to nominate, review and discuss about candidacy for Board of Directors, evaluate the independence of the Independent Non-Executive Director and propose appointment to the Board of Directors.
Nomination Committee Members
Mr. Fang Wen Quan – Executive Director (Chairman)
Mr. Lam Yat Fai – INED
Mr. Chiu Sung Hong– INED
Risk Management Committee
Set up to assist the Board of Directors to take heed of and make informed decision on operational risks, design the risk management strategy direction and risk control management system in an attempt to reduce the operational risk to the minimum.
Risk Management Committee members
Mr. Chiu Sung Hong – INED (Chairman)
Mr. Fang Wen Quan – Executive Director
Mr. Lam Yat Fai – INED
Remuneration Committee
Set up to propose the remuneration policy and framework for Directors and senior management staff.
Remuneration Committee Members
Mr. Chiu Sung Hong –INED(Chairman)
Mr. Fang Wen Quan – Non-Executive Director
Mr. Lam Yat Fai –INED
Dr. Xian Yanfang - INED